Bioxyne Limited (ASX:BXN)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011
Plant Based	5.44M
Plant Based Growth	6.32%
Manufacture/Sales	3.00M
Wholesale	886.91K
Wholesale Growth	1984.14%
Direct	104.69K
Direct Growth	3825.42%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011
United Kingdom/Europe/Japan	5.44M
United Kingdom/Europe/Japan Growth	6.32%
Australia	3.00M
United States	886.91K
United States Growth	1984.14%
Asia	104.69K
Asia Growth	3825.42%